GRIN2A and breast cancer: Mutations in GRIN2A, GATA3 and KDM6A which have been identified in melanoma, breast cancer and recently identified as a candidate driver of pancreatic carcinogenesis, respectively, were only identified within the EUS FNA cytology smear specimens.